Cellular and molecular mechanisms underlying NOD 2 risk‐associated polymorphisms in Crohn's disease
The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Summary: The discovery that polymorphisms in the NOD 2 (nucleotide‐binding oligomerization domain containing 2) gene are associated with a greatly increased risk for the development of C rohn's disease has provided a means to achieve a deeper understanding of the dysregulation of mucosal immune responses to the commensal intestinal organisms that is thought to underlie this disease. NOD 2 is a NOD‐like receptor (NLR) family member that senses and responds to bacterial wall peptides; thus, the most widely held view of the relation of the NOD 2 polymorphisms with C rohn's disease is that these polymorphisms lead to deficient immune responses to gut bacteria, and these, in turn, lead to quantitative or qualitative changes in the bacterial population in the gut lumen or lamina propria that cause inflammation at this site. Initially, this view was based mainly on the observation that defective NOD 2 function can result in reduced α‐defensin production by intestinal Paneth cells and that such impairment leads to loss of host defense against gut bacteria. In this review, we reconsider this possibility and marshal evidence that it is not in fact likely to be a prime element of C rohn's disease causation. More recently, evidence has been accumulating that the NOD 2 dysfunction leads to C rohn's inflammation by inducing changes in the gut microbiome that influence immune effector or regulatory function. We review the strengths and weaknesses of this emerging hypothesis. Finally, we consider the possibility that NOD 2 dysfunction can lead to inflammation because of a second and somewhat overlooked aspect of its function, that as an immunoregulator of innate immune responses. In particular, we review the body of evidence that NOD 2 stimulation activates a cross‐tolerance response that downregulates and thus prevents excessive TLR responses that cause C rohn's inflammation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease
The International IBD Genetics Consortium (IIBDGC), Jostins, L., Ripke, S., Weersma, R. K., Duerr, R. H., McGovern, D. P., Hui, K. Y., Lee, J. C., Philip Schumm, L., Sharma, Y., et al. (2012) · Nature · doi:10.1038/nature11582 · Cited by 4,722 · cited 1×
“In the last decade, genome-wide association studies have uncovered over 150 genes that have coding or non-coding polymorphisms occurring at a higher frequency in patients with Crohn’s disease (CD) than controls and that therefore are assumed to be contributing to its pathogenesis (1).”
BackgroundTreg induction by a rationally selected mixture of Clostridia strains from the human microbiota
Atarashi, K., Tanoue, T., Oshima, K., Suda, W., Nagano, Y., Nishikawa, H., Fukuda, S., Saito, T., Narushima, S., Hase, K., et al. (2013) · Nature · doi:10.1038/nature12331 · Cited by 2,872 · cited 2×
“This possibility also derives support from a recent study of germ-free mice whose intestinal microbiome was replete with bacteria from human feces, 17 strains of Clostridial organisms acting in concert have been identified as the gut bacteria that are specifically able to induce suppressor cells and that administratio…”
BackgroundResultRound, J. L., & Mazmanian, S. K. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909122107 · Cited by 2,233 · cited 1×
“A case can also be made that decreases in Bacteroidetes bacteria also lead to decreased mucosal regulation, as this bacterial phylum harbors organisms (Bacteroides fragilis) that have been shown to induce regulatory cells in mice (36, 37).”
BackgroundDarfeuille-Michaud, A., Boudeau, J., Bulois, P., Neut, C., Glasser, A.-L., Barnich, N., Bringer, M.-A., Swidsinski, A., Beaugerie, L., & Colombel, J.-F. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.04.061 · Cited by 1,566 · cited 1×
“First, AIEC are found in only about a quarter of CD patients and then only in the small intestine; in addition, they occur in some 6% of controls and in substantial numbers of CD patients without small bowel disease (39).”
BackgroundTravassos, L. H., Carneiro, L. A. M., Ramjeet, M., Hussey, S., Kim, Y.-G., Magalhães, J. G., Yuan, L., Soares, F., Chea, E., Le Bourhis, L., et al. (2010) · Nature Immunology · doi:10.1038/ni.1823 · Cited by 1,306
Low counts of Faecalibacterium prausnitzii in colitis microbiota
Sokol, H., Seksik, P., Furet, J. P., Firmesse, O., Nion-Larmurier, I., Beaugerie, L., Cosnes, J., Corthier, G., Marteau, P., & Doré, J. (2009) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20903 · Cited by 1,275
Enteric defensins are essential regulators of intestinal microbial ecology
Salzman, N. H., Hung, K., Haribhai, D., Chu, H., Karlsson-Sjöberg, J., Amir, E., Teggatz, P., Barman, M., Hayward, M., Eastwood, D., et al. (2010) · Nature Immunology · doi:10.1038/ni.1825 · Cited by 1,156
Vaishnava, S., Behrendt, C. L., Ismail, A. S., Eckmann, L., & Hooper, L. V. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808723105 · Cited by 1,019
Swidsinski, A., Weber, J., Loening-Baucke, V., Hale, L. P., & Lochs, H. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.7.3380-3389.2005 · Cited by 894
Garrett, W. S., Gallini, C. A., Yatsunenko, T., Michaud, M., DuBois, A., Delaney, M. L., Punit, S., Karlsson, M., Bry, L., Glickman, J. N., et al. (2010) · Cell Host & Microbe · doi:10.1016/j.chom.2010.08.004 · Cited by 788 · cited 1×
“Such microflora, however, fall short of being a true colitogenic microflora that can cause disease in a normal, unperturbed mouse, such as the microflora developing in so-called TRUC mice (RAG2deficient and T-bet double-deficient mice) that develop a colitis associated with a microflora that transmits disease to co-ho…”
Background
Cited by
Human Intestinal Barrier Function in Health and Disease
König, J., Wells, J., Cani, P. D., García-Ródenas, C. L., MacDonald, T., Mercenier, A., Whyte, J., Troost, F., & Brummer, R.-J. (2016) · Clinical and Translational Gastroenterology · doi:10.1038/ctg.2016.54 · Cited by 780
Weber, D., Oefner, P. J., Hiergeist, A., Koestler, J., Gessner, A., Weber, M., Hahn, J., Wolff, D., Stämmler, F., Spang, R., et al. (2015) · Blood · doi:10.1182/blood-2015-04-638858 · Cited by 195
NOD2 and inflammation: current insights
Negroni, A., Pierdomenico, M., Cucchiara, S., & Stronati, L. (2018) · Journal of Inflammation Research · doi:10.2147/jir.s137606 · Cited by 197
Takagawa, T., Kitani, A., Fuss, I., Levine, B., Brant, S. R., Peter, I., Tajima, M., Nakamura, S., & Strober, W. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aan8162 · Cited by 145
“Prime examples of this include (i) the disease polymorphisms associated with the NOD2 (nucleotide binding oligomerization domain containing 2) gene that adversely affect host defense function or an immunoregulatory function that limits excessive innate responses (2) and (ii) the protective polymorphisms associated wit…”
BackgroundSelf-citationRecent advances in the development of RIPK2 modulators for the treatment of inflammatory diseases
Pham, A.-T., Ghilardi, A. F., & Sun, L. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1127722 · Cited by 40
“Dysregulation of NOD/RIPK2 signaling is implicated in the development of several inflammatory diseases, including sarcoidosis, Blau syndrome, Crohn’s disease (CD), and ulcerative colitis (UC) (Hugot et al., 2001; Lesage et al., 2002; Hysi et al., 2005; McGovern et al., 2005; Tanabe et al., 2006; Stronati et al., 2008;…”
Background
Metadata
- Authors
- Strober, W., Asano, N., Fuss, I., Kitani, A., & Watanabe, T.
- Venue
- Immunological Reviews
- Publisher
- Wiley
- Published
- 2014-06-19
- Volume
- 260
- Issue
- 1
- Pages
- 249-260
- ISSN
- 0105-2896 (ISSN-L)
- 1600-065X
- OpenAlex
- W1979891329
- Cited by
- 104
- References
- 12
- FWCI
- 1.60
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cellular and molecular mechanisms underlying NOD 2 risk‐associated polymorphisms in Crohn's disease. https://app.cochat.ai/papers/10.1111/imr.12193
- The paper
- Strober, W., Asano, N., Fuss, I., Kitani, A., & Watanabe, T. (2014). Cellular and molecular mechanisms underlying NOD 2 risk‐associated polymorphisms in Crohn's disease. Immunological Reviews. https://doi.org/10.1111/imr.12193
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.